Mereo BioPharma Group (Mereo BioPharma Group) PB Ratio : 8.20 (As of May. 14, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Mereo BioPharma Group PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-14), Mereo BioPharma Group's share price is $2.96. Mereo BioPharma Group's Book Value per Share for the quarter that ended in Dec. 2023 was $0.36. Hence, Mereo BioPharma Group's PB Ratio of today is 8.20.

The historical rank and industry rank for Mereo BioPharma Group's PB Ratio or its related term are showing as below:

MREO' s PB Ratio Range Over the Past 10 Years
Min: 0.33 Med: 1.24 Max: 11.54
Current: 8.59

During the past 9 years, Mereo BioPharma Group's highest PB Ratio was 11.54. The lowest was 0.33. And the median was 1.24.

MREO's PB Ratio is ranked worse than
87.58% of 1312 companies
in the Biotechnology industry
Industry Median: 2.48 vs MREO: 8.59

During the past 12 months, Mereo BioPharma Group's average Book Value Per Share Growth Rate was -12.40% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Mereo BioPharma Group was -29.60% per year. The lowest was -46.50% per year. And the median was -37.30% per year.

Back to Basics: PB Ratio

Mereo BioPharma Group PB Ratio Historical Data

The historical data trend for Mereo BioPharma Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group PB Ratio Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

1.22

1.57

1.82

6.40

Mereo BioPharma Group Semi-Annual Data
	Jun15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial												1.57	1.55	1.82	2.33	6.40

Competitive Comparison of Mereo BioPharma Group's PB Ratio

For the Biotechnology subindustry, Mereo BioPharma Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mereo BioPharma Group's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's PB Ratio falls into.

Mereo BioPharma Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Mereo BioPharma Group's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	2.96	/	0.361
	=	8.20

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Mereo BioPharma Group (NAS:MREO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Mereo BioPharma Group PB Ratio Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group (Mereo BioPharma Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (NAS:MREO) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

MAH0:Germany MAH0:Germany

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.